Generic (active ingredient)Registered with DGDA
Moxifloxacin: brands in Bangladesh
The DGDA registry lists 110 registered products with the generic Moxifloxacin, under 86 brand names from 60 companies.
Dosage forms: Drops, Tablet, Injection, Ointment. Strengths: 5 mg/mL, 160 mg/100 mL, 400 mg, 500 mg/100 gm, 500 mg/100 mL.
Registered Moxifloxacin products
Grouped by strength and dosage form. For information only; this is not a recommendation to substitute one product for another.
400 mg · Tablet (43 products)
5 mg/mL · Eye Drops (34 products)
500 mg/100 mL · Eye Drops (17 products)
| Brand | Company | DAR no. |
|---|---|---|
| CINAGEN | Navana Pharmaceuticals Ltd. | 267-0396-074 |
| Cinagen-XG | Navana Health Care Limited | 348-0097-074 |
| Cinagen-XG | Navana Pharmaceuticals Ltd. | 267-0397-074 |
| Edrumox | Edruc Ltd. | 009-0286-074 |
| Floromox XG | Ibn Sina Pharmaceutical Ind. Ltd. | 239-0517-074 |
| Floxalone Ophthalmic Solution | Drug International Ltd. | 400-0516-074 |
| Fomox XG | Monicopharma Limited | 138-0159-074 |
| MFC-XG | Nipa Pharmaceuticals Ltd. | 174-0236-074 |
| Moxigen GX | General Pharmaceuticals Ltd. | 362-0097-074 |
| Moxilocin XG | Opsonin Pharma Limited | 025-1420-074 |
| MOXLOCIN XG Eye Drops | Pacific Pharmaceuticals Ltd. | 160-0339-074 |
| Moxlon | Albion Laboratories Ltd. | 096-0429-074 |
| Moxquin Eye Drops | Incepta Pharmaceuticals Ltd. | 366-0288-074 |
| Moxquin XG | Incepta Pharmaceuticals Ltd. | 116-0996-074 |
| Odycin Ultra | Beximco Pharmaceuticals Ltd. | 186-0991-074 |
| Optimox XG | Aristopharma Limited | 143-0608-074 |
| Vigalon | UNIDO Pharmaceuticals Ltd. | 460-0001-074 |
160 mg/100 mL · IV Infusion (11 products)
| Brand | Company | DAR no. |
|---|---|---|
| Eramox IV | Beacon Pharmaceuticals PLC | 341-0189-023 |
| Flomox | OSL Pharma Ltd. | 259-0088-023 |
| Iventi | Square Pharmaceuticals PLC | 321-0216-023 |
| Maximox IV | Orion Infusion Ltd. | 292-0037-023 |
| Moxibac | Popular Infusions Ltd. | 347-0031-023 |
| Moxibac | Popular Pharmaceuticals PLC | 336-0604-023 |
| Moxifix IV Infusion | The ACME Laboratories Ltd. | 036-1207-023 |
| Moxilocin 400mg IV | Opsonin Pharma Limited | 025-1507-023 |
| Moxquin 400 IV | Incepta Pharmaceuticals Ltd. | 366-0383-023 |
| Moxquin 400 mg | Incepta Pharmaceuticals Ltd. | 116-0970-023 |
| Optimox IV Infusion | Aristopharma Limited | 143-0761-023 |
500 mg/100 gm · Eye Ointment (5 products)
| Brand | Company | DAR no. |
|---|---|---|
| Floromox Eye Ointment | Ibn Sina Pharmaceutical Ind. Ltd. | 239-0516-052 |
| Moxifen Eye Ointment | General Pharmaceuticals Ltd. | 362-0114-052 |
| Moxigen | General Pharmaceuticals Ltd. | 240-0114-052 |
| Moxilocin | Opsonin Pharma Limited | 025-1611-052 |
| Optimox | Aristopharma Limited | 143-0661-052 |
Dosage forms available
Each link lists all registered medicines in that dosage form.
Top companies for Moxifloxacin
Companies with the most registered Moxifloxacin products.
- Incepta Pharmaceuticals Ltd.7 products
- Aristopharma Limited5 products
- General Pharmaceuticals Ltd.5 products
- Opsonin Pharma Limited5 products
- Ibn Sina Pharmaceutical Ind. Ltd.4 products
- Navana Pharmaceuticals Ltd.4 products
- Square Pharmaceuticals PLC4 products
- Beximco Pharmaceuticals Ltd.3 products
- Drug International Ltd.3 products
- Monicopharma Limited3 products
Related generics
Combinations containing Moxifloxacin
Frequently asked questions
How many Moxifloxacin brands are registered in Bangladesh?
In which dosage forms and strengths is Moxifloxacin registered?
Which companies have the most registered Moxifloxacin products?
Can one Moxifloxacin brand be used instead of another?
About this data
Source: DGDA Registered Drug Products (Directorate General of Drug Administration (DGDA), via DGHS national terminology server), retrieved 4 Oct 2026. “Registered” means the product appears in the official registry; it does not confirm current availability or price. Prices are not shown because no verified price source exists yet.
This site provides general medicine and price information only. It is not medical advice. Do not start, stop or change any medicine without consulting a qualified healthcare professional.